Genomic Valley Biotech (GVBL) Shareholding Pattern

NSE: GVBL • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 46.06%
FII Holding 0.00%
DII Holding 0.00%
Public Holding 52.25%
Total Shareholders 2,522
As of Dec 2025
View the latest shareholding pattern of Genomic Valley Biotech (GVBL) including promoter, FII, DII, and public holdings. Track GVBL ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See GVBL DCF)

Genomic Valley Biotech (GVBL) Shareholding Summary

  • Promoters have decreased holding from 46.72% to 46.06% in Dec 2025
  • FII/FPI holding remains unchanged at 0.00% in Dec 2025
  • DII holding remains unchanged at 0.00% in Dec 2025
  • Public holding has decreased from 52.53% to 52.25% in Dec 2025
  • Number of shareholders increased from 2,459 to 2,522 in Dec 2025

GVBL Quarterly Ownership Changes

Quarter-over-quarter changes for Genomic Valley Biotech from Sept 2025 to Dec 2025.

Promoter Holding Change
Sept 2025 to Dec 2025
-0.66%
FII Holding Change
Sept 2025 to Dec 2025
No Change
DII Holding Change
Sept 2025 to Dec 2025
No Change
Public Holding Change
Sept 2025 to Dec 2025
-0.28%

Genomic Valley Biotech (GVBL) Quarterly Shareholding Trends

Visual breakdown of GVBL ownership distribution over time. Learn more about GVBL financial statements.

Promoter
FII
DII
Public
Government

Rising institutional holdings in GVBL often correlate with improved fundamentals. Check out Genomic Valley Biotech market cap.

Genomic Valley Biotech (GVBL) Shareholding Data

Download complete GVBL ownership data for offline analysis. Discover GVBL dividend history.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 46.06% 0.00% 0.00% 0.00% 52.25% 1.69% 100.00% 2,522
Sept 2025 46.72% 0.00% 0.00% 0.00% 52.53% 0.76% 100.01% 2,459
Jun 2025 46.72% 0.00% 0.00% 0.00% 52.79% 0.49% 100.00% 2,460
Mar 2025 46.78% 0.00% 0.00% 0.00% 52.62% 0.60% 100.00% 2,504
Dec 2024 46.83% 0.00% 0.00% 0.00% 52.59% 0.58% 100.00% 2,497
Sept 2024 54.67% 0.00% 0.00% 0.00% 44.74% 0.59% 100.00% 2,128
Jun 2024 64.14% 0.00% 0.00% 0.00% 35.06% 0.81% 100.01% 1,540
Mar 2024 64.20% 0.00% 0.00% 0.00% 34.45% 1.35% 100.00% 1,334
Dec 2023 65.04% 0.00% 0.00% 0.00% 32.70% 2.25% 99.99% 1,014
Sept 2023 66.32% 0.00% 0.00% 0.00% 32.66% 1.02% 100.00% 591
Jun 2023 67.18% 0.00% 0.00% 0.00% 32.17% 0.65% 100.00% 381
Mar 2023 67.18% 0.00% 0.00% 0.00% 32.17% 0.65% 100.00% 380
Dec 2022 67.85% 0.00% 0.00% 0.00% 32.15% 0.00% 100.00% 375
Sept 2022 67.85% 0.00% 0.00% 0.00% 32.15% 0.00% 100.00% 375
Jun 2022 67.85% 0.00% 0.00% 0.00% 32.15% 0.00% 100.00% 371
Mar 2022 67.85% 0.00% 0.00% 0.00% 32.15% 0.00% 100.00% 371
Dec 2021 67.85% 0.00% 0.00% 0.00% 32.15% 0.00% 100.00% 371
Sept 2021 67.85% 0.00% 0.00% 0.00% 32.15% 0.00% 100.00% 371
Jun 2021 67.85% 0.00% 0.00% 0.00% 32.15% 0.00% 100.00% 371
Mar 2021 67.85% 0.00% 0.00% 0.00% 32.15% 0.00% 100.00% 0

GVBL promoter holding above 50% indicates strong insider confidence. Explore the Genomic Valley Biotech P/E valuation for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 46.06% 0.00% 0.00% 0.00% 52.25% 1.69% 100.00% 2,522
Sept 2025 46.72% 0.00% 0.00% 0.00% 52.53% 0.76% 100.01% 2,459
Jun 2025 46.72% 0.00% 0.00% 0.00% 52.79% 0.49% 100.00% 2,460
Mar 2025 46.78% 0.00% 0.00% 0.00% 52.62% 0.60% 100.00% 2,504
Dec 2024 46.83% 0.00% 0.00% 0.00% 52.59% 0.58% 100.00% 2,497
Sept 2024 54.67% 0.00% 0.00% 0.00% 44.74% 0.59% 100.00% 2,128
Jun 2024 64.14% 0.00% 0.00% 0.00% 35.06% 0.81% 100.01% 1,540
Mar 2024 64.20% 0.00% 0.00% 0.00% 34.45% 1.35% 100.00% 1,334
Dec 2023 65.04% 0.00% 0.00% 0.00% 32.70% 2.25% 99.99% 1,014
Sept 2023 66.32% 0.00% 0.00% 0.00% 32.66% 1.02% 100.00% 591
Jun 2023 67.18% 0.00% 0.00% 0.00% 32.17% 0.65% 100.00% 381
Mar 2023 67.18% 0.00% 0.00% 0.00% 32.17% 0.65% 100.00% 380

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 46.06% 0.00% 0.00% 0.00% 52.25% 1.69% 100.00% 2,522
Dec 2024 46.83% 0.00% 0.00% 0.00% 52.59% 0.58% 100.00% 2,497
Dec 2023 65.04% 0.00% 0.00% 0.00% 32.70% 2.25% 99.99% 1,014
Dec 2022 67.85% 0.00% 0.00% 0.00% 32.15% 0.00% 100.00% 375
Dec 2021 67.85% 0.00% 0.00% 0.00% 32.15% 0.00% 100.00% 371

Year-over-year trends reveal long-term ownership shifts.

Understanding Genomic Valley Biotech (GVBL) Shareholding Pattern

Genomic Valley Biotech shareholding pattern reveals who owns GVBL stock and how ownership changes over time. High promoter stakes in GVBL often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your GVBL trades. GVBL book value

Combine GVBL ownership analysis with price movements and financial performance for a complete investment picture. (See GVBL share price history)